NEVVI Medicare utilization intelligence
or

← back

Provider profile

PENNIE, MICHELLE MD

Dermatology · NPI 1497932784 · ENGLEWOOD, FL

2
Groups
50
Codes · 2024
10,480
Disclosed services

PENNIE, MICHELLE is a Dermatology in ENGLEWOOD, FL, a member of 2 medical groups, who billed 50 distinct codes to Medicare Part B in 2024.

Groups: BLISS DERMATOLOGY LLC (VENICE, FL) · SUNCOAST SKIN SOLUTIONS (LUTZ, FL) — member of 2 groups; the volumes below are this clinician's personal volume and are not attributed to any single group

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

10,480
disclosed services
50
codes billed to Medicare Part B
Prior year · CY2023 4,591 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
17003 Destruction of precancer skin growth, 2-14 growths
17000 Destruction of precancer skin growth, 1 growth
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
11102 Biopsy of related skin growth, first growth
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
17110 Destruction of skin growth, 1-14 growths
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
11103 Biopsy of related skin growth, each additional growth
17311 Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
17312 Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks
13132 Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg
Q4194 Novachor, per square centimeter
17004 Destruction of precancer skin growth, 15 or more growths
13121 Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm
17262 Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm
11900 Injection into skin growth, 1-7 growths
17261 Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm
17313 Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks
11104 Punch biopsy, first skin growth
12032 Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm
11602 Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm
29580 Strapping, unna boot
69100 Biopsy of ear
J9190 Injection, fluorouracil, 500 mg
11401 Removal of noncancer skin growth of body, arms, or legs, 0.6-1.0 cm
J7308 Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)
14060 Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less
99202 New patient office or other outpatient visit with straightforward medical decision making, if using time, 15 minutes or more
96574 Application of light with debridement to destroy precancer skin growth
12052 Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm
13101 Complicated repair of wound of trunk, 2.6-7.5 cm
14040 Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.0 sq cm or less
14041 Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.1-30.0 sq cm
15275 Application of skin substitute graft to wound of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 25.0 sq cm or less of wound 100.0 sq cm or less
11603 Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm
96372 Injection of drug or substance under skin or into muscle
11402 Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm
12031 Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less
13152 Complicated repair of wound of eyelids, nose, ears, or lip, 2.6-7.5 cm
17272 Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm
15260 Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less
97597 Removal of tissue from wound, 20.0 sq cm or less
13151 Complicated repair of wound of eyelids, nose, ears, or lip, 1.1-2.5 cm
11403 Removal of noncancer skin growth of body, arms, or legs, 2.1-3.0 cm
17260 Destruction of cancer skin growth of trunk, arms, or legs, 0.5 cm or less
12051 Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.5 cm or less
17271 Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.